{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:28:44Z","timestamp":1792466924473,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11886-022-01636-1","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T16:02:59Z","timestamp":1642435379000},"page":"163-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular Morbidity in Individuals with Impaired FEV1"],"prefix":"10.1007","volume":"24","author":[{"given":"Joscilin","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-0166","authenticated-orcid":false,"given":"Nils Patrick","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"1636_CR1","doi-asserted-by":"publisher","unstructured":"Ford ES, Croft JB, Mannino DM, et al. COPD surveillance\u2014United States, 1999\u20132011. Chest.\u00a02013;144:284\u2013305.\u00a0https:\/\/doi.org\/10.1378\/chest.13-0809.","DOI":"10.1378\/chest.13-0809"},{"key":"1636_CR2","doi-asserted-by":"publisher","unstructured":"Mannino DM, McBurnie MA, Tan W, et al. Restricted spirometry in the burden of lung disease study. Int J Tuberc Lung Dis.\u00a02012;16:1405\u20131411.\u00a0https:\/\/doi.org\/10.5588\/ijtld.12.0054.","DOI":"10.5588\/ijtld.12.0054"},{"key":"1636_CR3","doi-asserted-by":"publisher","unstructured":"Pelkonen M, Tukiainen H, Tervahauta M, et al. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax.\u00a02000;55:746\u2013750. https:\/\/doi.org\/10.1136\/thorax.55.9.746.","DOI":"10.1136\/thorax.55.9.746"},{"key":"1636_CR4","doi-asserted-by":"publisher","unstructured":"Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ.\u00a01996;313:711\u2013715; discussion 715\u2013716.\u00a0https:\/\/doi.org\/10.1136\/bmj.313.7059.711.","DOI":"10.1136\/bmj.313.7059.711"},{"key":"1636_CR5","doi-asserted-by":"publisher","unstructured":"Martinez FJ, Han MK, Allinson JP, et al. At the root: defining and halting progression of early chronic obstructive pulmonary disease. Am J Respir Crit Care Med.\u00a02018;197:1540\u20131551. https:\/\/doi.org\/10.1164\/rccm.201710-2028PP.","DOI":"10.1164\/rccm.201710-2028PP"},{"key":"1636_CR6","doi-asserted-by":"publisher","unstructured":"Conrad N, Judge A, Canoy D, et al. Temporal trends and patterns in mortality after incident heart failure: a longitudinal analysis of 86000 individuals. JAMA Cardiol.\u00a02019;4:1102\u20131111. https:\/\/doi.org\/10.1001\/jamacardio.2019.3593.","DOI":"10.1001\/jamacardio.2019.3593"},{"key":"1636_CR7","doi-asserted-by":"publisher","unstructured":"Ma J, Ward EM, Siegel RL, et al. Temporal trends in mortality in the United States, 1969\u20132013. JAMA.\u00a02015;314:1731\u20131739.\u00a0https:\/\/doi.org\/10.1001\/jama.2015.12319.","DOI":"10.1001\/jama.2015.12319"},{"key":"1636_CR8","doi-asserted-by":"publisher","unstructured":"Kalhan R, Arynchyn A, Colangelo LA, et al. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med.\u00a02010;123:468 e461\u2013467.\u00a0https:\/\/doi.org\/10.1016\/j.amjmed.2009.07.037.","DOI":"10.1016\/j.amjmed.2009.07.037"},{"key":"1636_CR9","doi-asserted-by":"publisher","unstructured":"Cazzola M, Bettoncelli G, Sessa E, et al. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80:112\u2013119.\u00a0https:\/\/doi.org\/10.1159\/000281880.","DOI":"10.1159\/000281880"},{"key":"1636_CR10","doi-asserted-by":"publisher","unstructured":"Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65:956\u2013962.\u00a0https:\/\/doi.org\/10.1136\/thx.2009.128082.","DOI":"10.1136\/thx.2009.128082"},{"key":"1636_CR11","doi-asserted-by":"publisher","unstructured":"Sode BF, Dahl M and Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish Nationwide Study of 7.4 million individuals. Eur Heart J.\u00a02011;32:2365\u20132375.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehr338.","DOI":"10.1093\/eurheartj\/ehr338"},{"key":"1636_CR12","doi-asserted-by":"publisher","unstructured":"Behar S, Panosh A, Reicher-Reiss H, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med 1992;93:637\u2013641.\u00a0https:\/\/doi.org\/10.1016\/0002-9343(92)90196-i.","DOI":"10.1016\/0002-9343(92)90196-i"},{"key":"1636_CR13","doi-asserted-by":"publisher","unstructured":"Soriano JB, Rigo F, Guerrero D, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010;137:333\u2013340.\u00a0https:\/\/doi.org\/10.1378\/chest.09-1264.","DOI":"10.1378\/chest.09-1264"},{"key":"1636_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Duong M, Islam S, Rangarajan S, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study. Lancet Glob Health. 2019;7:e613-e623.\u00a0https:\/\/doi.org\/10.1016\/S2214-109X(19)30070-1. FEV1 is an independent predictor of CVD, even across the clinically normal range (mild to moderate impairment).","DOI":"10.1016\/S2214-109X(19)30070-1"},{"key":"1636_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.ANNEPIDEM.2005.04.008","volume":"16","author":"SM Curkendall","year":"2006","unstructured":"Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63\u201370. https:\/\/doi.org\/10.1016\/J.ANNEPIDEM.2005.04.008.","journal-title":"Ann Epidemiol"},{"key":"1636_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-8703(83)90532-X","volume":"105","author":"WB Kannel","year":"1983","unstructured":"Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: The Framingham study. Am Heart J. 1983;105:311\u20135. https:\/\/doi.org\/10.1016\/0002-8703(83)90532-X.","journal-title":"Am Heart J"},{"key":"1636_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/aje\/kwg276","volume":"158","author":"EB Schroeder","year":"2003","unstructured":"Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;158:1171\u201381. https:\/\/doi.org\/10.1093\/aje\/kwg276.","journal-title":"Am J Epidemiol"},{"key":"1636_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2147\/COPD.S242809","volume":"15","author":"A Bikov","year":"2020","unstructured":"Bikov A, Lange P, Anderson JA, et al. FEV1 is a stronger mortality predictor than FVC in patients with moderate copd and with an increased risk for cardiovascular disease. Int J COPD. 2020;15:1135\u201342. https:\/\/doi.org\/10.2147\/COPD.S242809.","journal-title":"Int J COPD"},{"key":"1636_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1164\/rccm.200805-725OC","volume":"178","author":"RB Hubbard","year":"2008","unstructured":"Hubbard RB, Smith C, Le Jeune I, et al. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med. 2008;178:1257\u201361. https:\/\/doi.org\/10.1164\/rccm.200805-725OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1636_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.anai.2017.03.012","volume":"118","author":"H Liu","year":"2017","unstructured":"Liu H, Fu Y, Wang K. Asthma and risk of coronary heart disease: a meta-analysis of cohort studies. Ann Allergy Asthma Immunol. 2017;118:689\u201395. https:\/\/doi.org\/10.1016\/j.anai.2017.03.012.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1636_CR21","doi-asserted-by":"publisher","unstructured":"Canepa M, Straburzynska-Migaj E, Drozdz J, et al. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018;20:100\u2013110.\u00a0https:\/\/doi.org\/10.1002\/ejhf.964.","DOI":"10.1002\/ejhf.964"},{"key":"1636_CR22","doi-asserted-by":"publisher","unstructured":"Lopez-Sanchez M, Munoz-Esquerre M, Huertas D, et al. High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study. PLoS One.\u00a02013;8:e68034.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0068034.","DOI":"10.1371\/journal.pone.0068034"},{"key":"1636_CR23","doi-asserted-by":"publisher","unstructured":"Stone IS, Barnes NC, James WY, et al. Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. a randomized controlled trial. Am J Respir Crit Care Med. 2016;193:717\u2013726.\u00a0https:\/\/doi.org\/10.1164\/rccm.201508-1647OC.","DOI":"10.1164\/rccm.201508-1647OC"},{"key":"1636_CR24","doi-asserted-by":"publisher","unstructured":"\u2022 Hohlfeld JM, Vogel-Claussen J, Biller H, et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med.\u00a02018;6:368\u2013378. https:\/\/doi.org\/10.1016\/s2213-2600(18)30054-7. This study demonstrates that bronchodilators have a direct hemodynamic effect on left-ventricular function. Early use of bronchodialtors in patients with COPD could serve as a preventative measure to reduce CVD in patients with COPD.","DOI":"10.1016\/s2213-2600(18)30054-7"},{"key":"1636_CR25","doi-asserted-by":"publisher","unstructured":"Engstrom G, Melander O, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalisations. Thorax. 2010;65:633\u2013638.\u00a0https:\/\/doi.org\/10.1136\/thx.2010.135392.","DOI":"10.1136\/thx.2010.135392"},{"key":"1636_CR26","doi-asserted-by":"publisher","unstructured":"Cuttica MJ, Colangelo LA, Shah SJ, et al. Loss of lung health from young adulthood and cardiac phenotypes in middle age. Am J Respir Crit Care Med. 2015;192:76\u201385.\u00a0https:\/\/doi.org\/10.1164\/rccm.201501-0116OC.","DOI":"10.1164\/rccm.201501-0116OC"},{"key":"1636_CR27","unstructured":"Chronic Cor Pulmonale. Report of an expert committee. World Health Organ Tech Rep Ser. 1961;213:35."},{"key":"1636_CR28","doi-asserted-by":"publisher","unstructured":"Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;5.\u00a0https:\/\/doi.org\/10.1183\/13993003.01914-2018.","DOI":"10.1183\/13993003.01914-2018"},{"key":"1636_CR29","doi-asserted-by":"publisher","unstructured":"Boerrigter BG, Bogaard HJ, Trip P, et al. Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension. Chest. 2012;142:1166\u20131174.\u00a0https:\/\/doi.org\/10.1378\/chest.11-2798.","DOI":"10.1378\/chest.11-2798"},{"key":"1636_CR30","doi-asserted-by":"publisher","unstructured":"McCord J, Borzak S. Multifocal atrial tachycardia. Chest. 1998;113: 203\u2013209.\u00a0https:\/\/doi.org\/10.1378\/chest.113.1.203.","DOI":"10.1378\/chest.113.1.203"},{"key":"1636_CR31","doi-asserted-by":"publisher","unstructured":"Shih HT, Webb CR, Conway WA, et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest. 1988;94:44\u201348.\u00a0https:\/\/doi.org\/10.1378\/chest.94.1.44.","DOI":"10.1378\/chest.94.1.44"},{"key":"1636_CR32","doi-asserted-by":"publisher","unstructured":"Buch P, Friberg J, Scharling H, et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003;21:1012\u20131016.\u00a0https:\/\/doi.org\/10.1183\/09031936.03.00051502.","DOI":"10.1183\/09031936.03.00051502"},{"key":"1636_CR33","doi-asserted-by":"publisher","unstructured":"Li J, Agarwal SK, Alonso A, et al. Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2014;129:971\u2013980.\u00a0https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004050.","DOI":"10.1161\/CIRCULATIONAHA.113.004050"},{"key":"1636_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0167-5273(02)00402-3","volume":"88","author":"T T\u00fckek","year":"2003","unstructured":"T\u00fckek T, Yildiz P, Atilgan D, et al. Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease. Int J Cardiol. 2003;88:199\u2013206. https:\/\/doi.org\/10.1016\/s0167-5273(02)00402-3.","journal-title":"Int J Cardiol"},{"key":"1636_CR35","doi-asserted-by":"publisher","unstructured":"Iribarren C, Round AD, Peng JA, et al. Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Ann Noninvasive Electrocardiol. 2014;19:490\u2013500. https:\/\/doi.org\/10.1111\/anec.12157.","DOI":"10.1111\/anec.12157"},{"key":"1636_CR36","doi-asserted-by":"publisher","unstructured":"Gaita F, Giustetto C, Bianchi F, et al. Short QT Syndrome: a familial cause of sudden death. Circulation. 2003;108:965\u2013970.\u00a0https:\/\/doi.org\/10.1161\/01.CIR.0000085071.28695.C4.","DOI":"10.1161\/01.CIR.0000085071.28695.C4"},{"key":"1636_CR37","doi-asserted-by":"publisher","unstructured":"Warnier MJ, Blom MT, Bardai A, et al. Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case-control study. PLoS One. 2013;8:e65638.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0065638.","DOI":"10.1371\/journal.pone.0065638"},{"key":"1636_CR38","doi-asserted-by":"publisher","unstructured":"Lahousse L, Niemeijer MN, van den Berg ME, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36:1754\u20131761.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehv121.","DOI":"10.1093\/eurheartj\/ehv121"},{"key":"1636_CR39","doi-asserted-by":"publisher","unstructured":"Liao KM, Kuo LT, Lu HY. Increased risk of peripheral arterial occlusive diseases in patients with chronic obstructive pulmonary disease: a nationwide study in Taiwan. Int J Chron Obstruct Pulmon Dis. 2019;14:1455\u20131464.\u00a0https:\/\/doi.org\/10.2147\/COPD.S202029.","DOI":"10.2147\/COPD.S202029"},{"key":"1636_CR40","doi-asserted-by":"publisher","unstructured":"Houben-Wilke S, Jorres RA, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the COPD and systemic consequences-comorbidities network study. Am J Respir Crit Care Med. 2017;195:189\u2013197.\u00a0https:\/\/doi.org\/10.1164\/rccm.201602-0354OC.","DOI":"10.1164\/rccm.201602-0354OC"},{"key":"1636_CR41","doi-asserted-by":"publisher","unstructured":"Tschopp J, Dumont P, Hayoz D. True prevalence of COPD and its association with peripheral arterial disease in the internal medicine ward of a tertiary care hospital. Swiss Med Wkly. 2017;147:w14460.\u00a0https:\/\/doi.org\/10.4414\/smw.2017.14460.","DOI":"10.4414\/smw.2017.14460"},{"key":"1636_CR42","doi-asserted-by":"publisher","unstructured":"Terzikhan N, Lahousse L, Verhamme KMC, et al. COPD is associated with an increased risk of peripheral artery disease and mortality. ERJ Open Res. 2018;4.\u00a0https:\/\/doi.org\/10.1183\/23120541.00086-2018.","DOI":"10.1183\/23120541.00086-2018"},{"key":"1636_CR43","doi-asserted-by":"publisher","unstructured":"Willey J, Mentias A, Vaughan-Sarrazin M, et al. Epidemiology of lower extremity peripheral artery disease in veterans. J Vasc Surg. 2018;68:527\u2013535 e525.\u00a0https:\/\/doi.org\/10.1016\/j.jvs.2017.11.083.","DOI":"10.1016\/j.jvs.2017.11.083"},{"key":"1636_CR44","doi-asserted-by":"publisher","unstructured":"Yao CW, Shen TC, Lu CR, et al. Asthma is associated with a subsequent risk of peripheral artery disease: a longitudinal population-based study. Medicine (Baltimore).\u00a02016;95:e2546.\u00a0https:\/\/doi.org\/10.1097\/MD.0000000000002546.","DOI":"10.1097\/MD.0000000000002546"},{"key":"1636_CR45","doi-asserted-by":"publisher","unstructured":"Tuleta I, Skowasch D, Aurich F, et al. Asthma is associated with atherosclerotic artery changes. PLoS One. 2017;12:e0186820. https:\/\/doi.org\/10.1371\/journal.pone.0186820.","DOI":"10.1371\/journal.pone.0186820"},{"key":"1636_CR46","doi-asserted-by":"publisher","unstructured":"Portegies ML, Lahousse L, Joos GF, et al. Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam study. Am J Respir Crit Care Med. 2016;193:251\u2013258.\u00a0https:\/\/doi.org\/10.1164\/rccm.201505-0962OC.","DOI":"10.1164\/rccm.201505-0962OC"},{"key":"1636_CR47","doi-asserted-by":"publisher","unstructured":"Truelsen T, Prescott E, Lange P, et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol. 2001;30:145\u2013151.\u00a0https:\/\/doi.org\/10.1093\/ije\/30.1.145.","DOI":"10.1093\/ije\/30.1.145"},{"key":"1636_CR48","doi-asserted-by":"publisher","unstructured":"Gulsvik AK, Gulsvik A, Skovlund E, et al. The association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Commun Health. 2012;66:1030\u20131036.\u00a0https:\/\/doi.org\/10.1136\/jech-2011-200312.","DOI":"10.1136\/jech-2011-200312"},{"key":"1636_CR49","doi-asserted-by":"publisher","unstructured":"Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999\u20132008. BMC Pulm Med. 2012;12:26.\u00a0https:\/\/doi.org\/10.1186\/1471-2466-12-26.","DOI":"10.1186\/1471-2466-12-26"},{"key":"1636_CR50","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jacc.2018.06.049","volume":"72","author":"OM Silvestre","year":"2018","unstructured":"Silvestre OM, Nadruz W, Querejeta Roca G, et al. Declining lung function and cardiovascular risk: the ARIC study. J Am Coll Cardiol. 2018;72:1109\u201322. https:\/\/doi.org\/10.1016\/j.jacc.2018.06.049.","journal-title":"J Am Coll Cardiol"},{"key":"1636_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-6818-x","volume":"19","author":"SM Ching","year":"2019","unstructured":"Ching SM, Chia YC, Lentjes MAH, et al. FEV1 and total cardiovascular mortality and morbidity over an 18 years follow-up population-based prospective EPIC-NORFOLK study. BMC Public Health. 2019;19:1\u201310. https:\/\/doi.org\/10.1186\/s12889-019-6818-x.","journal-title":"BMC Public Health"},{"key":"1636_CR52","doi-asserted-by":"publisher","unstructured":"Kim SY, Lim H, Lim JS, et al. Analysis of the relationship between adult asthma and stroke: a longitudinal follow-up study using the Korean national sample cohort. Biomed Res Int. 2019;2019:8919230.\u00a0https:\/\/doi.org\/10.1155\/2019\/8919230.","DOI":"10.1155\/2019\/8919230"},{"key":"1636_CR53","doi-asserted-by":"publisher","unstructured":"Wen LY, Ni H, Li KS, et al. Asthma and risk of stroke: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2016;25:497\u2013503.\u00a0https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.11.030.","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.030"},{"key":"1636_CR54","doi-asserted-by":"publisher","unstructured":"Strand LB, Tsai MK, Wen CP, et al. Is having asthma associated with an increased risk of dying from cardiovascular disease? A prospective cohort study of 446 346 Taiwanese adults. BMJ Open. 2018;8:e019992.\u00a0https:\/\/doi.org\/10.1136\/bmjopen-2017-019992.","DOI":"10.1136\/bmjopen-2017-019992"},{"key":"1636_CR55","doi-asserted-by":"publisher","unstructured":"Pollevick ME, Xu KY, Mhango G, et al. The relationship between asthma and cardiovascular disease: an examination of the Framingham offspring study. Chest. 2021;159:1338\u20131345.\u00a0https:\/\/doi.org\/10.1016\/j.chest.2020.11.053.","DOI":"10.1016\/j.chest.2020.11.053"},{"key":"1636_CR56","doi-asserted-by":"publisher","unstructured":"Kalhan R, Tran BT, Colangelo LA, et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010;5:e11431.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0011431.","DOI":"10.1371\/journal.pone.0011431"},{"key":"1636_CR57","doi-asserted-by":"publisher","unstructured":"Kalhan R, Dransfield MT, Colangelo LA, et al. Respiratory symptoms in young adults and future lung disease. The CARDIA lung study. Am J Respir Crit Care Med. 2018;197:1616\u20131624. https:\/\/doi.org\/10.1164\/rccm.201710-2108OC.","DOI":"10.1164\/rccm.201710-2108OC"},{"key":"1636_CR58","doi-asserted-by":"publisher","unstructured":"Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax. 2007;62:237\u2013241.\u00a0https:\/\/doi.org\/10.1136\/thx.2006.068379.","DOI":"10.1136\/thx.2006.068379"},{"key":"1636_CR59","doi-asserted-by":"publisher","unstructured":"King GG. Cutting edge technologies in respiratory research: lung function testing. Respirology. 2011;16:883\u2013890.\u00a0https:\/\/doi.org\/10.1111\/j.1440-1843.2011.02013.x.","DOI":"10.1111\/j.1440-1843.2011.02013.x"},{"key":"1636_CR60","doi-asserted-by":"publisher","unstructured":"Silverman EK. Genetics of COPD. Annu Rev Physiol.\u00a02020;82:413\u2013431.\u00a0https:\/\/doi.org\/10.1146\/annurev-physiol-021317-121224.","DOI":"10.1146\/annurev-physiol-021317-121224"},{"key":"1636_CR61","doi-asserted-by":"publisher","unstructured":"Zhang L, Valizadeh H, Alipourfard I, et al. Epigenetic modifications and therapy in chronic obstructive pulmonary disease (COPD): An Update Review. COPD. 2020;17:333\u2013342.\u00a0https:\/\/doi.org\/10.1080\/15412555.2020.1780576.","DOI":"10.1080\/15412555.2020.1780576"},{"key":"1636_CR62","doi-asserted-by":"publisher","unstructured":"Sun P, Ye R, Wang C, et al. Identification of proteomic signatures associated with COPD frequent exacerbators. Life Sci. 2019;230:1\u20139. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.047.","DOI":"10.1016\/j.lfs.2019.05.047"},{"key":"1636_CR63","doi-asserted-by":"publisher","unstructured":"Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11:5886.\u00a0https:\/\/doi.org\/10.1038\/s41467-020-19701-0.","DOI":"10.1038\/s41467-020-19701-0"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:25:22Z","timestamp":1647689122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01636-1","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"4 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}